Update on leishmaniases;Les leishmanioses: Actualites

Presse Medicale

Volumn 29, Issue 18, 2000, Pages 1019-1026

  Dedet, J P ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION SENSITIVITY; LEISHMANIASIS; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; REVIEW; ANIMAL; ARTICLE; BED; DISEASE CARRIER; DOG; DOG DISEASE; GENETICS; IMMUNOSUPPRESSIVE TREATMENT; PARASITOLOGY; PUBLIC HEALTH;

INSECTICIDE;

ANIMALS; BEDDING AND LINENS; DOG DISEASES; DOGS; HUMANS; IMMUNOSUPPRESSION; INSECT VECTORS; INSECTICIDES; LEISHMANIASIS; PUBLIC HEALTH;

EID: 0034690436     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Dedet JP. Leishmanies-Leishmanioses : clinique et thérapeutique. Encyclopédie Médico-chirurgicale (Elsevier, Paris), Maladies infectieuses 1995 ; 8-506-A-20:6 p.
2. Desjeux P. Aspects de santé publique et lutte. In: Les Leishmanioses, Dedet JP ed. Ellipses, Paris, 1999 ; 227-36.
3. Lumsden WHR. Biochemical taxonomy of Leishmania. Trans R Soc trop Med Hyg 1974 ; 68:74-5.
4. Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In : The leishmaniases in biology and medicine. Peters W, Killick-Kendrick R eds. Academic Press, London 1987 ; 1:1-20.
5. Gardener PJ, Chance ML, Peters W. Biochemical taxonomy of Leishmania. II. Electrophoretic variation of malate dehydrogenase. Ann Trop Med Parasit 1974 ; 68:317-25.
6. Pratlong F, Lanotte G. Identification , taxonomie et phylogénèse In: Les Leishmanioses. Dedet JP ed. Ellipses, Paris, 1999 ; 21-39.
7. Rioux JA, Lanotte G, Serres E, Pratlong F, Bastien P, Périeres J. Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Annls Parasitol Hum Comp 1990 ; 65:111-25.
8. Rioux JA, Lanotte G. Apport de la cladistique à l'analyse du genre Leishmania Ross, 1903 (Kinetoplastida-Trypanosomaticae). Corollaires épidémiologiques. Biosystema 1993 ; 8:79-90.
9. Ravel C, Wincker P, Blaineau C. Biologie moléculaire de Leishmania. In: Les Leishmanioses. Dedet JP ed. Ellipses, Paris, 1999 ; 59-62.
10. Wincker P, Ravel C, Blaineau C et al. The Leishmania genome comprises 36 chromosomes conserved across widely divergent human pathogenic species. Nucl Acids Res 1996 ; 24:1688-94.
11. Britto C, Ravel C, Bastien P et al. Conserved linckage groups associated with large-scale chromosomal rearrangements between Old World and New World Leishmania genomes. Genes 1998 ; 222:107-17.
12. Ravel C, Dubessay P, Blackwell JM, vens AC. The complete chromosomal organization of the reference strain of the Leishmania genome project, L. major "Friedlin". Parasitol Today 1998 ; 14:301-3.
13. Myler PJ, Audleman L, De Vos T et al. Leishmania major Friedlin chromosome 1 has an unusual distribution of protein-coding genes. Proc Nat Acad Sci USA 1999 ; 96:2902-6.
14. Antoine JC, Lang T, Prina E. Biologie cellulaire de Leishmania. In: Les Leishmaniases. Dedet JP ed Ellipses ; Paris 1999 ; 41-62.
15. Titus RG, Ribeiro JMC. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 1988 ; 239:1306-8.
16. Belkaid Y, Kamhawi S, Modi G et al. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 1998 ; 188:1941-3.
17. Vidor E, Dereure J, Pratlong F et al. Le chancre d'inoculation dans la leishmaniose canine à Leishmania infantum. Etude d'une cohorte en région cévenole. Prat Med chir Animal comp 1991 ; 26:133-7.
18. Rioux JA, Lanotte G, Pratlong F et al. La leishmaniose cutanée autochtone dans le Sud-Est de la France. Résultats d'une enquête éco-épidémiologique dans les Pyrénées-Orientales. Med Mol Infect 1985 ; 11:650-6.
19. Pratlong F, Rispail P, Moreno G et al. Leishmaniose cutanée à Leishmania infantum MON-24, observée à Grasse (Alpes-Maritimes) chez un enfant tunisien. Ann Parasitol Hum Comp 1989 ; 64:506-9.
20. Pratlong F, Bastien P, Perello R, Lami P, Dedet JP. Human cutaneous leishmaniasis caused by Leishmania donovani sensu stricto in Yemen. Trans R Soc Trop Med Hyg 1995 ; 89:398-9.
21. Pratlong F, Dedet JP, Marty P et al. Leishmania-human immunodeficiency virus co-infection in the Mediterranean Basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J Infect Dis 1995 ; 172:323-6.
22. Pratlong F, Lambert M, Bastien P, Dedet JP. Leishmanioses et immunodépression. Aspects biocliniques actuels. Rev Franç Labor 1997 ; 291:161-8.
23. Develoux M, Diallo S, Dieng Y et al. Diffuse cutaneous leishmaniasis due to Leishmania major in Sénégal. Trans R Soc Trop Med Hyg 1996 ; 90:396-7.
24. Mahe A, Gessain A, Huerre M, Pratlong F, Dedet, P. Eγthrodermic diffuse cutaneous leishmaniasis with Sezany syndrome. Lancet 1996 ; 348:405-6.
25. Solbach W, Laskay T. Leishmania major infection: the overture. Parasitol Today 1995 ; 11:394-7.
26. Locksley RM, Heinzel FP, Holaday BJ et al. Induction of Th1 and Th2 CD4+ subsets during murine L. major infection. Res Immunol 1991 ; 142:29-32.
27. Blackwell JM. Genetic susceptibility to leishmanial infections : studies in mice and man. Parasitol 1996 ; 112:S67-74.
28. Gorham JD, Guler ML, Steen RG et al. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type response. Proc Natl Acad Sci USA 1996 ; 93:12467-72.
29. Alcaïs A, Abel L, David C, Torrez ME, Flandre P, Dedet JP. Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recent exposed bolivian population. Am J Hum Genet 1997 ; 61:968-79.
30. Pavlovskij EN. [On natural focality of infections and parasitic diseases. Vest Akad Nauik SSSR 1939; 10:98-108] (en Russe).
31. Garnham PCC. The leishmaniasis, with special reference to the role of animal reservoirs Am Zool 1965 ; 5:141-51.
32. Deane LM, Grimaldi GJr. Leishmaniasis in Brazil. In: Leishmaniasis. Chang KP, Bray RS eds. Elsevier, Amsterdam, 1998 ; 247-81.
33. Dedet JP. Leishmania et leishmanioses du continent américain. Ann Inst Pasteur/Actualités 1993 ; 4:3-25.
34. Thakur CP, Kumar K. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol 1992 ; 86:355-9.
35. Seamar J, Mercer AJ, Sondorp E. The epidemic of visceral leishmaniasis in northern Sudan during 1984-1996 : course, impact, clinical outcome and costs. Trans R Soc Trop Hyg 1996 ; 90:22.
36. UNAIDS/WHO Leishmania & HIV in gridlock. WHO/CTD/LEISH/98.9 Acd. 1 ; 1998:25p.
37. Alvar J. Leishmaniasis and AIDS co-infection: the Spanish example. Parasitol Today 1994 ; 10:160-3
38. Marty P. Le Fichoux Y, Pratlong F, Gari-Toussaint M. Human visceral eishmaniasis in Alpes-Maritimes: epidemological characteristics for the period 1985-1992. Trans R Soc Trop Med Hyg 1994 ; 88:33-4.
39. Gradoni L, Scalone A, Gramiccia M, Troiani M. Epidemiological surveillance of leishmaniasis in HIV-1 infected individuals in Italy.AIDS 1996 ; 10:785-91.
40. Alvar J, Jimenez M. Could infected drug-users be potential Leishmania infantum reservoirs ? AIDS 1994 ; 8:854.
41. Dereure J, Pratlong F, Reynes J, Basset D, Bastien P, Dedet JP. Haemoculture as a tool for diagnosing visceral leishmaniasis in HIV-negative and HIV-positive patients: interest for parasite identification. Bull WHO 1998 ; 76:203-6.
42. Lachaud L, Dereure J, Chabbert E et al. Optimized PCR using patient blood samples for diagnosis and follow-up of visceral leishmaniasis, with special reference to AIDS patients. J Clin Microbiol 2000 ; 38:236-40.
43. Campino L, Santos-Gomes G, Pratlong F, Dedet JP, Abranches P. The isolation of leishmania donovani MON-18, from an AIDS patient in Portugal: possible needle transmission. Parasite 1994 ; 1:391-2.
44. Dedet JP, Pratlong F. Leishmania, Trypanosoma and Monoxerous Trypanosomatids as emerging opportunistic agents. J Eukaryot Microbiol 2000 ; 47:37-9.
45. Badaro R, Jones TC, Lorenço R et al. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 1986 ; 154:639-49.
46. Ho M, Siongok TK, Lyerly WH, Smith DH. Prevalence and disease spectrum in a new locus of visceral leishmaniasis in Kenya. Trans R Soc Trop Med Hyg 1982 ; 76:741-6.
47. Marty P, Le Fichoux Y, Giordana D, Brugnetti A. Leishmanin reaction in the human population of a highly endemic focus of canine leishmaniasis in Alpes-Maritimes, France. Trans R Soc Trop Med Hyg 1992 ; 86:249-50.
48. Kubar J, Quaranta JF, Marty P, Lelievre A, Le Fichoux Y, Aufeuvre JP. Transmission of Leishmania infantum by blood donors. Nature Medicine 1997 ; 3:368.
49. Dedet JP. Traitement. In: Les Leishmanioses. Dedet JP ed. Ellipses, Paris, 1999 ; 213-26
50. Herwaldt B, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (pentostam) and review of pertinent clinical studies. Am J trop Med Hyg 1992 ; 46:296-306.
51. OMS. Fiches modèles OMS d'information à l'usage des prescripteurs : Médicaments utilisés en parasitologie. Organisation Mondiale de la Santé, Genève ; 1993 : 146 p.
52. Davidson RN, Di Martino L, Gradoni L et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Q J Med 1994 ; 87:75-81.
53. Belazzoug S, Neal RA. Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria. Trans R Soc Trop Med Hyg 1986 ; 80:670-1.
54. Badaro R, Falcoff E, Badaro FS et al. Treatment of visceral leishmaniasis with pentavalent antimony and interferon-gamma. N Engl J Med 1990 ; 322:16-21.
55. Falcoff E, Taranto NJ, Remondegui CE et al. Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon gamma and pentavalent antimonial compounds. Trans R Soc Trop Med Hyg 1993 ; 88:95-7.
56. Jha TK, Sundar S, Thakur CP et al. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 1999 ; 341:1795-800.
57. Tayeh A, Jalouk L, Al Khiami AM. A cutaneous leishmaniasis control trial using pyrethroid-impregnated bednets in villages near Aleppo, Syria. WHO/LEISH/1997/97:41.
58. Killick-Kendrick R, Killick-Kendrick M, Focheux C, Dereure J, Puech MP, Cadiergues MC. Protection of dogs from bites of phlebotomine sandflies by deltamethrin collar for control of canine leishmaniasis. Med Vet Entomol 1997 ; 11:105-11.
59. Cruz Cubas AB, Rolland L, Monjour L. Vaccination anti-leishmanienne. In: Les leishmanioses. Dedet JP ed, Ellipses, Paris 1999 ; 237-45.
60. Guthmann JP, Calmet J, Rosales E, Cruz M, Chang J, Dedet JP. Patients' associations and the control of leishmaniasis in Peru. Bull Wld HO 1997 ; 75:39-44.